Respiratory Institute, Cleveland Clinic, Cleveland, OH.
Health Sciences Postgraduate Program, Federal University of Bahia, Ondina, Salvador, Bahia, Brazil.
Transplantation. 2018 Apr;102(4):681-687. doi: 10.1097/TP.0000000000001977.
The incidence of venous thromboembolism (VTE) after lung transplantation (LTX) varies significantly across studies. Two studies have suggested that these thrombotic events are associated with a lower posttransplant survival. Herein, we sought to determine the incidence, predictors, and impact of VTE on survival after LTX at a quaternary referral center.
This was a large cohort study of LTX recipients. Key outcome parameters were time to VTE after transplant and survival. Deep vein thrombosis (DVT) diagnosis required a positive ultrasound. Pulmonary embolism diagnosis required either a positive chest computed tomography angiogram or a high-probability ventilation/perfusion scan.
The overall incidence of VTE among 701 LTX recipients was 43.8%, of which 97.7% were DVT episodes, of which 71.3% were in the upper extremities. Predictors of VTE were prior history of DVT (hazard ratio [HR], 2.82; 95% confidence interval [CI], 1.49-5.37), days in intensive care (HR, 1.01; 95% CI, 1.01-1.02), and the use of extracorporeal membrane oxygenation (HR, 2.22; 95% CI, 1.43-3.45). Importantly, VTE predicted a lower posttransplant survival (HR, 1.70; 95% CI, 1.28-2.26), when occurring within or after the first 30 days. The location of the DVT, either upper extremity or below the knee, also predicted a poor survival.
VTE was frequent in LTX recipients and predicted a poor survival even when located in the upper extremities or below the knee. These data suggest that aggressive VTE screening/treatment protocols be implemented in post-LTX population.
肺移植(LTX)后静脉血栓栓塞症(VTE)的发生率在不同研究中差异很大。有两项研究表明,这些血栓事件与移植后生存率降低有关。在此,我们旨在确定在一家四级转诊中心,LTX 受者 VTE 的发生率、预测因素以及对生存率的影响。
这是一项 LTX 受者的大型队列研究。主要结局参数是移植后发生 VTE 的时间和生存率。深静脉血栓形成(DVT)的诊断需要阳性超声。肺栓塞的诊断需要阳性的胸部 CT 血管造影或高概率通气/灌注扫描。
701 例 LTX 受者中 VTE 的总发生率为 43.8%,其中 97.7%为 DVT 发作,其中 71.3%发生在上肢。VTE 的预测因素包括既往 DVT 病史(风险比 [HR],2.82;95%置信区间 [CI],1.49-5.37)、重症监护天数(HR,1.01;95%CI,1.01-1.02)和体外膜肺氧合(ECMO)的使用(HR,2.22;95%CI,1.43-3.45)。重要的是,VTE 发生在 30 天内或之后,预测移植后生存率较低(HR,1.70;95%CI,1.28-2.26)。DVT 的位置,无论是上肢还是膝下,也预测了较差的生存率。
VTE 在 LTX 受者中很常见,即使位于上肢或膝下,也预示着生存率较差。这些数据表明,应在 LTX 后人群中实施积极的 VTE 筛查/治疗方案。